June 27, 2025 | Shanghai, China
The 23rd edition of CPHI China 2025 has come to a successful close! Over the course of three vibrant days, YINO Biologic made a strong impression at booth E7B22 in the Shanghai New International Expo Centre, sharing our vision for a greener pharmaceutical solvent future rooted in non-food bio-based innovation.
1. Reimagining Sustainability — Starting from the Source
With the theme “From Nature to the Future,” YINO Biologic presented a comprehensive portfolio of non-food bio-based pharmaceutical solvents, developed fromn biomass waste like corn cobs. The booth drew strong interest from global pharmaceutical manufacturers, technical experts, and sustainability champions, all eager to explore responsible sourcing solutions for the next generation of pharma supply chains.
2. Technical Spotlight: 2-MeTHF Gains Global Attention
Among our featured products, 2-Methyltetrahydrofuran (2-MeTHF) stood out as a highlight of the show. Recognized for its low toxicity, high solubility, and excellent performance in Grignard reactions, 2-MeTHF is rapidly gaining traction as a green solvent of choice in high-end pharmaceutical synthesis.
Our non-food, traceable bio-based sourcing model resonated with many international visitors, who see it as a strategic direction for building more sustainable and transparent global supply networks.
3. Global Engagement: Trusted Dialogue, Future Collaboration
Throughout the exhibition, YINO Biologic welcomed hundreds of professional visitors from Europe, Southeast Asia, Japan, South Korea, India, and beyond. Our expert team delivered clear, in-depth presentations and shared practical application cases, earning high praise from attendees.
We not only gathered a wealth of qualified leads and initial cooperation interest, but also engaged in deep conversations with multinational pharmaceutical companies on low-carbon sourcing strategies and green supply chain integration. This growing trust affirms our commitment to innovation rooted in nature—and to becoming a reliable partner in the transition to a low-carbon pharmaceutical economy.
4. Moving Forward: This Is Just the Beginning for YINO Bio
CPHI China 2025 marked more than a conclusion—it was a launchpad for future collaboration and global impact. Looking ahead, YINO Biologic will continue to advance non-food bio-based platform technologies, expand our global presence, and help shape a greener, more sustainable pharmaceutical solvent industry through high-performance, traceable, and low-carbon product solutions.
We believe that green technology is more than a trend—it’s the foundation of trust, innovation, and growth. YINO Biologic is proud to stand at the intersection of science and sustainability, and we look forward to co-creating a healthier planet together with our global partners.
